FIGURE 6 India’s Pharmaceutical Exports, 2000–2022

of domestic drug demand, supplied 60% of glob-vation and global competitiveness. India's export al vaccine requirements, and produced 20% ofcomposition remains narrow, drug formulations world generics, exporting to nearly 200 countriesand biologicals accounting for 73.5%, bulk drugs (GoI 2025b). Export growth has slowed sincefor 17%, and vaccines and herbal products for ued reliance on imported raw materials, complex regulatory processes, periodic quality-controlAutomobile industry: The automobile industry is 1 The Act was enacted in the United States to balance the interests between the innovative drug industry and the generics industry. It aims to encourage innovative pharmaceutical enterprises to continue developing new drugs, while also enabling generics manufacturers to take advantage of relevant regulatory provisions to accelerate the market entry, lower the prices, and enhance